These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37829557)

  • 1. Prevalence of
    Nisar T; Arshad K; Abbas Z; Khan MA; Safdar S; Shaikh RS; Saeed A
    J Obes; 2023; 2023():6661858. PubMed ID: 37829557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified response of NAFLD patients with non-significant fibrosis in nutritional counseling according to GCKR rs1260326.
    Kaliora AC; Kalafati IP; Gioxari A; Diolintzi A; Kokkinos A; Dedoussis GV
    Eur J Nutr; 2018 Sep; 57(6):2227-2235. PubMed ID: 28695325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of Rs780094 and Rs1260326 Polymorphisms in GCKR Gene to Non-alcoholic Fatty Liver Disease: A Meta-Analysis Involving 26,552 Participants.
    Li J; Zhao Y; Zhang H; Hua W; Jiao W; Du X; Rui J; Li S; Teng H; Shi B; Yang X; Zhu L
    Endocr Metab Immune Disord Drug Targets; 2021; 21(9):1696-1708. PubMed ID: 33243135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals.
    Lin YC; Chang PF; Chang MH; Ni YH
    Am J Clin Nutr; 2014 Apr; 99(4):869-74. PubMed ID: 24477042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene.
    Tan HL; Zain SM; Mohamed R; Rampal S; Chin KF; Basu RC; Cheah PL; Mahadeva S; Mohamed Z
    J Gastroenterol; 2014 Jun; 49(6):1056-64. PubMed ID: 23800943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GCKR polymorphism influences liver fat content in patients with type 2 diabetes.
    Petit JM; Masson D; Guiu B; Rollot F; Duvillard L; Bouillet B; Brindisi MC; Buffier P; Hillon P; Cercueil JP; Verges B
    Acta Diabetol; 2016 Apr; 53(2):237-42. PubMed ID: 25976242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of GCKR Gene Polymorphisms with the Risk of Nonalcoholic Fatty Liver Disease and Coronary Artery Disease in a Chinese Northern Han Population.
    Gao H; Liu S; Zhao Z; Yu X; Liu Q; Xin Y; Xuan S
    J Clin Transl Hepatol; 2019 Dec; 7(4):297-303. PubMed ID: 31915598
    [No Abstract]   [Full Text] [Related]  

  • 8. Waist circumference mediates the association between rs1260326 in GCKR gene and the odds of lean NAFLD.
    Wu N; Li J; Zhang J; Yuan F; Yu N; Zhang F; Li D; Wang J; Zhang L; Shi Y; He G; Ji G; Liu B
    Sci Rep; 2023 Apr; 13(1):6488. PubMed ID: 37081070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between rs1260326 with the risk of NAFLD and the mediation effect of triglyceride on NAFLD in the elderly Chinese Han population.
    Yuan F; Gu Z; Bi Y; Yuan R; Niu W; Ren D; Zhang L; He G; Liu BC
    Aging (Albany NY); 2022 Mar; 14(6):2736-2747. PubMed ID: 35333773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique genetic variants of lean nonalcoholic fatty liver disease: a retrospective cohort study.
    Li J; Wu N; Yang Y; Zhai X; Yuan F; Zhang F; Yu N; Li D; Wang R; Wang J; Zhang L; Shi Y; He G; Liu B
    BMC Endocr Disord; 2023 Jan; 23(1):11. PubMed ID: 36627697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of GCKR and MBOAT7 genetic polymorphisms with non-alcoholic fatty liver disease.
    Chavan SU; Rathi P; Mandot A
    Clin Exp Hepatol; 2024 Mar; 10(1):39-46. PubMed ID: 38765903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents.
    Zusi C; Mantovani A; Olivieri F; Morandi A; Corradi M; Miraglia Del Giudice E; Dauriz M; Valenti L; Byrne CD; Targher G; Maffeis C
    Dig Liver Dis; 2019 Nov; 51(11):1586-1592. PubMed ID: 31255630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic determinants of steatosis and fibrosis progression in paediatric non-alcoholic fatty liver disease.
    Hudert CA; Selinski S; Rudolph B; Bläker H; Loddenkemper C; Thielhorn R; Berndt N; Golka K; Cadenas C; Reinders J; Henning S; Bufler P; Jansen PLM; Holzhütter HG; Meierhofer D; Hengstler JG; Wiegand S
    Liver Int; 2019 Mar; 39(3):540-556. PubMed ID: 30444569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms associated with nonalcoholic fatty liver disease in Uyghur population: a case-control study and meta-analysis.
    Cai W; Weng DH; Yan P; Lin YT; Dong ZH; Mailamuguli ; Yao H
    Lipids Health Dis; 2019 Jan; 18(1):14. PubMed ID: 30646922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents.
    Santoro N; Zhang CK; Zhao H; Pakstis AJ; Kim G; Kursawe R; Dykas DJ; Bale AE; Giannini C; Pierpont B; Shaw MM; Groop L; Caprio S
    Hepatology; 2012 Mar; 55(3):781-9. PubMed ID: 22105854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GCKR variants increase triglycerides while protecting from insulin resistance in Chinese children.
    Shen Y; Wu L; Xi B; Liu X; Zhao X; Cheng H; Hou D; Wang X; Mi J
    PLoS One; 2013; 8(1):e55350. PubMed ID: 23383164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GCKR and GCK polymorphisms are associated with increased risk of end-stage kidney disease in Chinese patients with type 2 diabetes: The Hong Kong Diabetes Register (1995-2019).
    Wang K; Shi M; Yang A; Fan B; Tam CHT; Lau E; Luk AOY; Kong APS; Ma RCW; Chan JCN; Chow E
    Diabetes Res Clin Pract; 2022 Nov; 193():110118. PubMed ID: 36243233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.
    Vaxillaire M; Cavalcanti-Proença C; Dechaume A; Tichet J; Marre M; Balkau B; Froguel P;
    Diabetes; 2008 Aug; 57(8):2253-7. PubMed ID: 18556336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects.
    Sliz E; Sebert S; Würtz P; Kangas AJ; Soininen P; Lehtimäki T; Kähönen M; Viikari J; Männikkö M; Ala-Korpela M; Raitakari OT; Kettunen J
    Hum Mol Genet; 2018 Jun; 27(12):2214-2223. PubMed ID: 29648650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of non-alcoholic fatty liver disease with total testosterone in non-overweight/obese men with type 2 diabetes mellitus.
    Yang LJ; Zhou JZ; Zheng YF; Hu X; He ZY; Du LJ; Gu X; Huang XY; Li J; Li YQ; Pan LY; Zhang XX; Gu XJ
    J Endocrinol Invest; 2023 Aug; 46(8):1565-1572. PubMed ID: 36725809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.